Silymarin Encapsulated Liposomal Formulation: An Effective Treatment Modality against Copper Toxicity Associated Liver Dysfunction and Neurobehavioral Abnormalities in Wistar Rats

Wilson’s disease causes copper accumulation in the liver and extrahepatic organs. The available therapies aim to lower copper levels by various means. However, a potent drug that can repair the damaged liver and brain tissue is needed. Silymarin has hepatoprotective, antioxidant, and cytoprotective...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Tuba Maryam, Nosheen Fatima Rana, Sultan M. Alshahrani, Farhat Batool, Misha Fatima, Tahreem Tanweer, Salma Saleh Alrdahe, Yasmene F. Alanazi, Ifat Alsharif, Fatima S. Alaryani, Amer Sohail Kashif, Farid Menaa
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2023-02-01
Seri Bilgileri:	Molecules
Konular:	silymarin liposome nanoparticles copper toxicity Wilson’s disease animal model histological examination
Online Erişim:	https://www.mdpi.com/1420-3049/28/3/1514
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!